← Eichor
Study identifier: NCT06884189 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Application of Plant Protection Products (PPP) in Apple Orchards

Condition: Dermal Exposure · Inhalative Exposure · Metabolites in Urine  ·  Sponsor: German Federal Institute for Risk Assessment

PhaseN/A
Planned participants16
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The aim of the aPPPle pilot study is to test feasibility and generate first results in preparation for a main study. The aPPPle study will investigate the exposure of operators, workers and residents to plant protection products (PPP) and potential physiological effects on blood biomarkers. The target plants are apple crops, as application occurs at higher altitudes and therefore higher drift/exposure is expected compared to ground-level application. The substances to be investigated are acetamiprid (an insecticide) and dithianon and dodine (two fungicides).

This description comes directly from the study's public registry record.

Talk to the study team

Prof. Dr. Cornelia Weikert  ·  +49 301841255000  ·  cornelia.weikert@bfr.bund.de

Dr. Anna Lechner  ·  +49 301841255015  ·  anna.lechner@bfr.bund.de

Always discuss trial participation with your own doctor first.

Locations (1)

Federal Institute for Risk AssessmentBerlin, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06884189